{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:25:14Z","timestamp":1787217914421,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amjms.2026.06.020","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:14:36Z","timestamp":1782317676000},"page":"224-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between reverse triiodothyronine and cardiac complications in patients with uncontrolled Graves' disease"],"prefix":"10.1016","volume":"372","author":[{"given":"Xiaoyun","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2026.06.020_bib0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/EJE-12-0585","article-title":"How could we improve the increased cardiovascular mortality in patients with overt and subclinical hyperthyroidism?","volume":"167","author":"Biondi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.amjms.2026.06.020_bib0002","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0254","article-title":"Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation","volume":"13","author":"Kostopoulos","year":"2024","journal-title":"Eur Thyroid J"},{"issue":"6","key":"10.1016\/j.amjms.2026.06.020_bib0003","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/105072502760143863","article-title":"Hyperthyroidism and the management of atrial fibrillation","volume":"12","author":"Shimizu","year":"2002","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.amjms.2026.06.020_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/joa3.70096","article-title":"Trends in atrial fibrillation and flutter mortality associated with disorders of thyroid gland in the United States from 1999 to 2020","volume":"41","author":"Ahmed","year":"2025","journal-title":"J Arrhythmia"},{"issue":"1","key":"10.1016\/j.amjms.2026.06.020_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jchf.2012.10.004","article-title":"Thyroid function in heart failure and impact on mortality","volume":"1","author":"Mitchell","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"25","key":"10.1016\/j.amjms.2026.06.020_bib0006","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/CIRCULATIONAHA.118.036859","article-title":"Thyroid and cardiovascular disease: research agenda for enhancing knowledge, prevention, and treatment","volume":"139","author":"Cappola","year":"2019","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.amjms.2026.06.020_bib0007","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.amjms.2026.06.020_bib0008","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.55730\/1300-0144.5927","article-title":"Thyroid and cardiovascular diseases","volume":"54","author":"Tan \u00d6ks\u00fcz","year":"2024","journal-title":"Turkish J Med Sci"},{"issue":"4","key":"10.1016\/j.amjms.2026.06.020_bib0009","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3803\/EnM.2020.728","article-title":"The association of overt and subclinical hyperthyroidism with the risk of cardiovascular events and cardiovascular mortality: meta-analysis and systematic review of cohort studies","volume":"35","author":"S0ohn","year":"2020","journal-title":"Endocrinol Metab (Seoul Korea)"},{"issue":"4","key":"10.1016\/j.amjms.2026.06.020_bib0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.eprac.2024.12.015","article-title":"Association of baseline thyroid stimulating hormone with In-hospital outcomes in patients with atrial fibrillation and coronary artery diseases","volume":"31","author":"Zhang","year":"2025","journal-title":"Endocr Pract: Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"10.1016\/j.amjms.2026.06.020_bib0011","article-title":"Prognostic impact of thyroid function in patients with incident heart failure: a nationwide study","author":"Petersen","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjms.2026.06.020_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2025.1583399","article-title":"Interpretable AI-driven multi-objective risk prediction in heart failure patients with thyroid dysfunction","volume":"7","author":"Iacoviello","year":"2025","journal-title":"Front Digital Health"},{"issue":"1","key":"10.1016\/j.amjms.2026.06.020_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47391-3","article-title":"Circulating thyroid hormones and clinical parameters of heart failure in men","volume":"13","author":"Turi\u0107","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjms.2026.06.020_bib0014","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.937958","article-title":"Measurement of serum ultra-sensitive thyroid-stimulating hormone levels to determine the risk for recurrence of atrial fibrillation following catheter ablation in 575 patients from a single center","volume":"29","author":"Li","year":"2023","journal-title":"Med Sci Monit: Int Med J Exp Clin Res"},{"key":"10.1016\/j.amjms.2026.06.020_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/11795514241285347","article-title":"Atrial fibrillation and associated factors among hyperthyroidism patients attending at university of gondar comprehensive specialized hospital, northwest Ethiopia","volume":"17","author":"Tefera","year":"2024","journal-title":"Clin Med Insights, Endocrinol Diabetes"},{"issue":"07","key":"10.1016\/j.amjms.2026.06.020_bib0016","first-page":"611","article-title":"Clinical Management of Hyperthyroidism Complicated with Liver Failure","volume":"39","author":"Feng","year":"2023","journal-title":"Chin J Endocrinol Metab"},{"issue":"09","key":"10.1016\/j.amjms.2026.06.020_bib0017","first-page":"746","article-title":"A retrospective cohort study exploring clinical characteristics and treatment of hyperthyroid cardiopathy","volume":"40","author":"Feng","year":"2024","journal-title":"Chin J Endocrinol Metab"},{"issue":"08","key":"10.1016\/j.amjms.2026.06.020_bib0018","first-page":"700","article-title":"Guidelines for the diagnosis and treatment of hyperthyroidism and thyrotoxicosis caused by other etiologies in China","volume":"38","author":"Endocrinology","year":"2022","journal-title":"Chin J Endocrinol Metab"},{"issue":"03","key":"10.1016\/j.amjms.2026.06.020_bib0019","first-page":"235","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2024","volume":"52","author":"Cardiology","year":"2024","journal-title":"Chin J Cardiol"},{"issue":"9","key":"10.1016\/j.amjms.2026.06.020_bib0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1507\/endocrj.K09E-159","article-title":"Decreasing brain natriuretic peptide levels after treatment for hyperthyroidism","volume":"56","author":"Ertugrul","year":"2009","journal-title":"Endocr J"},{"issue":"4","key":"10.1016\/j.amjms.2026.06.020_bib0021","first-page":"401","article-title":"Evaluation of brain natriuretic peptide levels in hyperthyroidism and hypothyroidism","volume":"100","author":"Ertugrul","year":"2008","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.amjms.2026.06.020_bib0022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2022.09.024","article-title":"Deiodinases control local cellular and systemic thyroid hormone availability","volume":"193","author":"K\u00f6hrle","year":"2022","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.amjms.2026.06.020_bib0023","first-page":"67","article-title":"Molecular basis of nongenomic actions of thyroid hormone","volume":"106","author":"Davis","year":"2018"},{"issue":"6","key":"10.1016\/j.amjms.2026.06.020_bib0024","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3390\/ijms19061804","article-title":"The type 3 deiodinase: epigenetic control of brain thyroid hormone action and neurological function","volume":"19","author":"Hernandez","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.amjms.2026.06.020_bib0025","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1006\/jmcc.1998.0930","article-title":"Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes","volume":"31","author":"Huang","year":"1999","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"10.1016\/j.amjms.2026.06.020_bib0026","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1210\/jc.2016-1935","article-title":"Serum thyroid function, mortality and disability in advanced old age: the newcastle 85+ study","volume":"101","author":"Pearce","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.amjms.2026.06.020_bib0027","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s40618-020-01482-4","article-title":"An update on non-thyroidal illness syndrome","volume":"44","author":"Fliers","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.amjms.2026.06.020_bib0028","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s40618-020-01408-0","article-title":"Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study","volume":"44","author":"Jabbar","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.amjms.2026.06.020_bib0029","first-page":"337","article-title":"Permanent atrial fibrillation in heart failure patients as another condition with increased reverse triiodothyronine concentration","volume":"37","author":"Jakowczuk","year":"2016","journal-title":"Neuro Endocrinol Lett"},{"issue":"5","key":"10.1016\/j.amjms.2026.06.020_bib0030","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3390\/jcm14051563","article-title":"Associations of free and reverse triiodothyronine with long-term all-cause mortality after acute ischemic stroke and acute myocardial infarction","volume":"14","author":"Taroza","year":"2025","journal-title":"J Clin Med"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926002417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926002417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:41:53Z","timestamp":1787215313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962926002417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0002962926002417"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2026.06.020","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between reverse triiodothyronine and cardiac complications in patients with uncontrolled Graves' disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2026.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}